Protective Effect of Rivaroxaban on Arteriosclerosis Obliterans in Rats Through Modulation of the Toll‑like Receptor 4/NF‑κB Signaling Pathway
Experimental and Therapeutic Medicine- Greece
doi 10.3892/etm.2019.7726
Full Text
Abstract
Available in
Date
July 3, 2019
Authors
Publisher
Spandidos Publications